Pharmaceutical formulations comprising rilpivirine hydrochloride, tenofovir alafenamide hemifumarate, and emtricitabine

The invention provides a multilayer tablet comprising rilpivirine hydrochloride, tenofovir alafenamide hemifumarate, and emtricitabine. The invention is particularly useful for the treatment of an HIV infection.

Saved in:
Bibliographic Details
Main Authors Sperger, Diana, Koziara, Joanna
Format Patent
LanguageEnglish
Published 22.02.2019
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The invention provides a multilayer tablet comprising rilpivirine hydrochloride, tenofovir alafenamide hemifumarate, and emtricitabine. The invention is particularly useful for the treatment of an HIV infection.
Bibliography:Application Number: NZ20160738524